imaginostics

Imaginostics receives investment support from Ideaship to support its development of innovative diagnostic solutions. Ideaship brings together the expertise of the Global Technology Transfer Group (GTT), which focuses on patent asset services, and the deep experience of the Panasonic Intellectual Property Corporation of America. The Ideaship fund investment focuses on patents and enables Imaginostics to access the strategic IP expertise and support from the

Imaginostics participated in the innovator’s pitch challenge hosted virtually at the Redefining Early Stage Investments (RESI) conference series. Highlighting its health technology and longevity platform, Imaginostics’ CEO describes the core technology solution and how Imaginostics is pushing the frontiers of medical imaging to enable precision medicine. The RESI conference was held between January 11 and 15, and is a unique global forum bringing together

Imaginostics CEO, Codi Gharagouzloo, discussed the Quantitative Neuroimaging Biomarkers for Precision Medicine at the NeuroTech 2020 event, as part of the Neuroimaging and related innovations segment held on December 2nd and 3rd. Other speakers at the event included founders, researchers, and professors. NeuroTech 2020 is described as “the digital congress for neurotechnology innovation and growth,” and it hosted the virtual and interactive conference with

Imaginostics participated in a start-up forum hosted by The Alzheimer’s Drug Discovery Foundation (ADDF) at their annual conference. CEO Codi Gharagouzloo, PhD, represented Imaginostics, as part of a forum that included other innovative start-ups from around the United States, Canada, and Europe. The annual conference brings together scientists from industry and academia and other professionals committed to drug discovery and related research on Alzheimer’s

Imagine treatments custom-tailored to the patient, rather than a one-size-fits-all approach. That was a key theme during Monday night’s precision medicine discussion at JLABS in New York City. Imaginostics CEO Dr. Codi Gharaghouzloo was one of four experts who served on the diverse panel. They discussed the current state of precision medicine and how the personalized medicine revolution impacts patient experience and clinical workflow.

Imaginostics spoke at the MIT Enterprise Forum Startup Spotlight on Wednesday night and won the Hustle award presented by Marc Gonyea, co-founder & managing partner of memoryBLUE. This award goes to the startup that most visibly demonstrates the highest aptitude to let nothing stop them from success. Event Details: http://startupspotlight.mitforumcambridge.org/

Baby Boomers are leading more active lives than their predecessors, and technology will play an important role in helping these individuals stay healthier longer. Dr. Codi Gharazouloo discussed these themes alongside three other tech innovators during the Harvard Catalyst Panel on healthy aging and technology on Thursday, June 6. Dr. Ghragouzloo described his invention, the QUTE-CE MRI method, which can possibly diagnose dementia many

The massive shift in the demographics of aging is generating unprecedented entrepreneurial opportunities. The world needs scalable, tech-enabled innovations that serve the evolving needs of the rapidly increasing older adult population. Dr. Codi Gharagouzloo discussed these issues this week at the MIT Enterprise Forum panel: Entrepreneurial Opportunities in the Longevity Economy. This emerging phenomenon – The Longevity Economy – will drive change in every